Trial Condition(s):

Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee

Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE) (SOPRANO)

Bayer Identifier:

16002

ClinicalTrials.gov Identifier:

NCT01444586

EudraCT Number:

Not Available

Study Completed

Trial Purpose

This is a local, prospective, multicenter, non-interventional, observational study. Primary objective is to describe how in "real life" thromboprophylaxis is carried out after the discharge from a hospital in the patients who undergo elective knee and hip replacement and who receive Xarelto during hospitalization.

Inclusion Criteria
- Male and female patients ≥ 18 years old 
 - Elective hip or knee replacement
 - Planned VTE prevention with Xarelto
 - Written informed consent
 - The decision for treatment type and duration is taken by the investigator and is made before inclusion into the study.
Exclusion Criteria
- Contraindications for the use of Xarelto in accordance with the effective instruction
 - Any reasons of medical and non-medical character, which in the opinion of the physician can hamper participation of the patient in NIS, including a potentially low compliance, impossibility of making the final visit due to distant place of residence of the patient.

Trial Summary

Enrollment Goal
2293
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Xarelto (Rivaroxaban, BAY59-7939)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many locations, Russia

Status
Completed
 

Trial Design